
Unlike pharma-specific conferences, HLTH USA is where scientists, commercial leaders, and R&D executives engage directly with the health systems, payers, employers, and investors who determine adoption and access. It’s where partnerships get sourced, collaborations get built, and the hard conversations about what’s working and what isn’t actually happen.
From GLP-1 economics and Medicare drug price negotiation to AI-driven drug discovery and direct-to-patient models, the HLTH USA agenda tackles the cross-sector dynamics pharma leaders can't get full visibility on from within their own industry events.
Learn more HLTH USA and be at the forefront of payer innovation. Empower yourself with the knowledge and connections to transform operations and reimbursement within your institution.